Children's Oncology Group: Oligodendroglioma trials

The registry lists 10 Oligodendroglioma studies with Children's Oncology Group as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 4Phase 2 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radiation Therapy in Treating Young Patients With GliomasCompletedNCT00238264Phase 2Results posted
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade GliomaCompletedNCT00077207Not applicableResults posted
• A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaActive, not recruitingNCT04978727Phase 1
• Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or LymphomaCompletedNCT01273090Phase 1
• Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsCompletedNCT00919750
• Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialCompletedNCT00890435
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT00352495Phase 1
• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
• Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
• Development of Strategies to Increase Enrollment in Clinical Trials for Children With CancerCompletedNCT00002485